We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

59 hedge funds and large institutions have $219M invested in ImmunityBio in 2015 Q3 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64% less call options, than puts

Call options by funds: $510K | Put options by funds: $1.41M

Holders
59
Holders Change
+59
Holders Change %
–
% of All Funds
1.65%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
59
Increased
–
Reduced
–
Closed
–
Calls
$510K
Puts
$1.41M
Net Calls
-$897K
Net Calls Change
-$897K

Top Buyers

Rank Fund Capital Flow
1
WCM
Wildcat Capital Management
New York
+$98.1M
2
CC
Callan Capital
California
+$79.3M
3
Capital Research Global Investors
Capital Research Global Investors
California
+$58.1M
4
Franklin Resources
Franklin Resources
California
+$42M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$33.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
26
Vanguard Group
Pennsylvania
$519K +$990K +45,367 New
State Street
27
State Street
Massachusetts
$485K +$926K +42,425 New
BG
28
BlackRock Group
United Kingdom
$480K +$913K +41,846 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$339K +$646K +29,593 New
Deutsche Bank
30
Deutsche Bank
Germany
$323K +$617K +28,265 New
BIM
31
BlackRock Investment Management
Delaware
$231K +$441K +20,194 New
Northern Trust
32
Northern Trust
Illinois
$202K +$384K +17,618 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$201K +$383K +17,560 New
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$139K +$264K +12,100 New
NI
35
Numeric Investors
Massachusetts
$139K +$264K +12,100 New
CS
36
Credit Suisse
Switzerland
$125K +$239K +10,955 New
Charles Schwab
37
Charles Schwab
California
$120K +$228K +10,431 New
Norges Bank
38
Norges Bank
Norway
$104K +$199K +9,100 New
TA
39
Teachers Advisors
New York
$77K +$147K +6,720 New
Citigroup
40
Citigroup
New York
$72K +$138K +6,301 New
TCIM
41
TIAA CREF Investment Management
New York
$67K +$127K +5,834 New
SEI Investments
42
SEI Investments
Pennsylvania
$43K +$81.7K +3,743 New
BA
43
BlackRock Advisors
Delaware
$29K +$54.8K +2,513 New
GGHC
44
Gilder Gagnon Howe & Co
New York
$28K +$53.8K +2,466 New
Wells Fargo
45
Wells Fargo
California
$27K +$51.4K +2,353 New
SO
46
STRS Ohio
Ohio
$25K +$48K +2,200 New
ClearBridge Investments
47
ClearBridge Investments
New York
$23K +$43.6K +2,000 New
UBS Group
48
UBS Group
Switzerland
$23K +$43.6K +2,000 New
Simplex Trading
49
Simplex Trading
Illinois
$19K +$37.3K +1,707 New
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$18K +$34.4K +1,575 New
1
2
3

IBRX Hedge Fund Activity: Q3 2015 in Review

59 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2015, worth a combined $219M.

Buyers outnumbered sellers: 59 funds opened new IBRX positions and 0 closed out — a net gain of 59 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Wildcat Capital Management, opening a new position worth an estimated $98.1M.

  • 59 institutional investors held ImmunityBio (IBRX) as of Q3 2015, up from 0 in Q2 2015.
  • Funds reported $219M of ImmunityBio stock for Q3 2015.
  • 59 funds opened new ImmunityBio positions in Q3 2015 and 0 closed out, a net change of +59 holders.
  • The largest ImmunityBio buyer in Q3 2015 was Wildcat Capital Management, an estimated $98.1M added.

Based on aggregated 13F filings for Q3 2015.